195 related articles for article (PubMed ID: 37906280)
1. Diabetes-associated breast cancer is molecularly distinct and shows a DNA damage repair deficiency.
Panigrahi G; Candia J; Dorsey TH; Tang W; Ohara Y; Byun JS; Minas TZ; Zhang A; Ajao A; Cellini A; Yfantis HG; Flis AL; Mann D; Ioffe O; Wang XW; Liu H; Loffredo CA; Napoles AM; Ambs S
JCI Insight; 2023 Dec; 8(23):. PubMed ID: 37906280
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
Elife; 2023 Mar; 12():. PubMed ID: 36883553
[TBL] [Abstract][Full Text] [Related]
3. A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.
McMullin RP; Wittner BS; Yang C; Denton-Schneider BR; Hicks D; Singavarapu R; Moulis S; Lee J; Akbari MR; Narod SA; Aldape KD; Steeg PS; Ramaswamy S; Sgroi DC
Breast Cancer Res; 2014 Mar; 16(2):R25. PubMed ID: 24625110
[TBL] [Abstract][Full Text] [Related]
4. Mutational Signatures in Breast Cancer: The Problem at the DNA Level.
Nik-Zainal S; Morganella S
Clin Cancer Res; 2017 Jun; 23(11):2617-2629. PubMed ID: 28572256
[TBL] [Abstract][Full Text] [Related]
5. The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis.
Kenny L
J Nucl Med; 2016 Feb; 57 Suppl 1():89S-95S. PubMed ID: 26834108
[TBL] [Abstract][Full Text] [Related]
6. CCR5 Governs DNA Damage Repair and Breast Cancer Stem Cell Expansion.
Jiao X; Velasco-Velázquez MA; Wang M; Li Z; Rui H; Peck AR; Korkola JE; Chen X; Xu S; DuHadaway JB; Guerrero-Rodriguez S; Addya S; Sicoli D; Mu Z; Zhang G; Stucky A; Zhang X; Cristofanilli M; Fatatis A; Gray JW; Zhong JF; Prendergast GC; Pestell RG
Cancer Res; 2018 Apr; 78(7):1657-1671. PubMed ID: 29358169
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Link between Diabetic Metabolic Dysregulation and Breast Cancer Progression.
Ahmed SBM; Radwan N; Amer S; Saheb Sharif-Askari N; Mahdami A; Samara KA; Halwani R; Jelinek HF
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511575
[TBL] [Abstract][Full Text] [Related]
8. Changes in DNA Damage Repair Gene Expression and Cell Cycle Gene Expression Do Not Explain Radioresistance in Tamoxifen-Resistant Breast Cancer.
Post AEM; Bussink J; Sweep FCGJ; Span PN
Oncol Res; 2020 Feb; 28(1):33-40. PubMed ID: 31046897
[TBL] [Abstract][Full Text] [Related]
9. The topography of mutational processes in breast cancer genomes.
Morganella S; Alexandrov LB; Glodzik D; Zou X; Davies H; Staaf J; Sieuwerts AM; Brinkman AB; Martin S; Ramakrishna M; Butler A; Kim HY; Borg Å; Sotiriou C; Futreal PA; Campbell PJ; Span PN; Van Laere S; Lakhani SR; Eyfjord JE; Thompson AM; Stunnenberg HG; van de Vijver MJ; Martens JW; Børresen-Dale AL; Richardson AL; Kong G; Thomas G; Sale J; Rada C; Stratton MR; Birney E; Nik-Zainal S
Nat Commun; 2016 May; 7():11383. PubMed ID: 27136393
[TBL] [Abstract][Full Text] [Related]
10. RepairSig: Deconvolution of DNA damage and repair contributions to the mutational landscape of cancer.
Wojtowicz D; Hoinka J; Amgalan B; Kim YA; Przytycka TM
Cell Syst; 2021 Oct; 12(10):994-1003.e4. PubMed ID: 34375586
[TBL] [Abstract][Full Text] [Related]
11. DNA damage repair functions and targeted treatment in breast cancer.
He C; Kawaguchi K; Toi M
Breast Cancer; 2020 May; 27(3):355-362. PubMed ID: 31898156
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia Differentially Affects Maternal and Fetal DNA Integrity and DNA Damage Response.
Moreli JB; Santos JH; Lorenzon-Ojea AR; Corrêa-Silva S; Fortunato RS; Rocha CR; Rudge MV; Damasceno DC; Bevilacqua E; Calderon IM
Int J Biol Sci; 2016; 12(4):466-77. PubMed ID: 27019630
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
Haricharan S; Bainbridge MN; Scheet P; Brown PH
Breast Cancer Res Treat; 2014 Jul; 146(1):211-20. PubMed ID: 24839032
[TBL] [Abstract][Full Text] [Related]
14. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
15. Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer.
Jiang Y; Liu Y; Hu H
Adv Exp Med Biol; 2017; 1026():105-123. PubMed ID: 29282681
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
[TBL] [Abstract][Full Text] [Related]
17. EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties.
Zhou K; Sun Y; Dong D; Zhao C; Wang W
Cell Death Dis; 2021 Sep; 12(9):844. PubMed ID: 34511602
[TBL] [Abstract][Full Text] [Related]
18. RDM1 promotes critical processes in breast cancer tumorigenesis.
Chen Y; Sun Z; Zhong T
J Cell Mol Med; 2019 Aug; 23(8):5432-5439. PubMed ID: 31222930
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.
D'Assoro AB; Leontovich A; Amato A; Ayers-Ringler JR; Quatraro C; Hafner K; Jenkins RB; Libra M; Ingle J; Stivala F; Galanis E; Salisbury JL
Int J Oncol; 2010 Nov; 37(5):1167-76. PubMed ID: 20878064
[TBL] [Abstract][Full Text] [Related]
20. E2F3 induces DNA damage repair, stem-like properties and therapy resistance in breast cancer.
Wei L; Bai Y; Na L; Sun Y; Zhao C; Wang W
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166816. PubMed ID: 37499929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
